zem-3

From diagnosis to determination

Patients with Alpha-1, a rare degenerative disease that affects the lungs, are typically overwhelmed by the diagnosis—and overloaded with information about treatment. So in addition to providing the drug Zemaira, CSL Behring delivers the financial, emotional and physical support services patients need to succeed. They asked us to package and promote these offerings in a compelling new way.

  • Fingerpaint is Agency of the Year according to MedAdNews

Patient community as therapy

Knowing that Alpha-1 patients form deep connections with their peers to stay motivated and help them overcome the challenges of living with the disease, we created Zemaira Carez—a dedicated support community. It offers ready access to financial assistance, wellness programs and a peer network that lets patients connect live with support specialists in an environment that feels warm and caring.